基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抑制剂 蛋白酶体(Proteases) Proteasome 抑制剂 MG132,蛋白酶体抑制剂 化合物 MG-132
  • 化合物 MG-132|T2154

化合物 MG-132|T2154

MG-132
133407-82-6
137 1mg 起订
276 5mg 起订
382 10mg 起订
上海 更新日期:2024-12-02

TargetMol中国(陶术生物)

VIP12年
联系人:邵小姐
电话:021-021-33632979拨打
手机:15002134094 拨打
邮箱:marketing@targetmol.com

产品详情:

中文名称:
化合物 MG-132
英文名称:
MG-132
CAS号:
133407-82-6
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格:
99.99%
产品类别:
抑制剂
货号:
T2154

Product Introduction

Bioactivity

名称MG-132
描述MG-132 (Z-Leu-Leu-Leu-al) is a 26S proteasome inhibitor (IC50=100 nM) that is cell-permeable and reversible. MG-132 acts as an autophagy activator and also induces apoptosis.
细胞实验The effect of MG132 on HeLa cell growth was determined by trypan blue exclusion cell counting or measuring MTT dye absorbance of living cells as previously described. In brief, cells (5x10^5 cells per well) were seeded in 24-well plates for cell counting, and cells (5x10^4 cells per well) were seeded in 96-well microtiter plates for the MTT assay. After exposure to indicated amounts of MG132 for 24 h, cells in 24-well plates or 96-well plates were collected with trypsin digestion for trypan blue exclusion cell counting or were used for the MTT assay. Twenty microliters of MTT solution (2 mg/ml in PBS) was added to each well of 96-well plates. The plates were again incubated for 4 h at 37?C. MTT solution in the medium was aspirated off and 200 μl of DMSO was added to each well to solubilize the formazan crystals formed in viable cells. Optical density was measured at 570 nm using a microplate reader. Each plate contained multiple wells at a given experimental condition and multiple control wells. This procedure was replicated for 2-4 plates per condition [3].
激酶实验Inhibitory activities of ZLLa1 and ZLLLal against m-calpain and 20S proteasome were measured by previously described methods.For the m-calpain inhibitory assay,the 0.5 ml reaction mixture contained 0.24% alkali-denatured casein,28 mM 2-mercaptoethanol,0.94 unit of m-calpain,ZLLal or ZLLLal,6 mM CaCl2,and 0.1M Tris-HC1 (pH 7.5).The reaction was started by the addition of m-calpain solution and stopped by the addition of 0.5 ml of 10% trichloroacetic acid after incubation at 30℃ for 15 min.After centrifugation at 1,300×g for 10 min,the absorbance of the supernatant at 280 nm was measured.The reaction mixture for the 20S proteasome inhibitory assay contained 0.1 M Tris-acetate,pH 7.0,20S proteasome,ZLLa1 or ZLLLal,and 25 μM substrate dissolved in dimethyl sulfoxide in a final volume of 1 ml.After incubation at 37℃ for 15 min,the reaction was stopped by the addition of 0.1 ml of 10% SDS and 0.9 ml of 0.1 M Tris-acetate,pH 9.0.The fluorescence of the reaction products was measured.To determine the IC50s against m-calpain and 20S proteasome,various concentrations of the synthetic peptide aldehydes were included in the assay mixture [1].
动物实验Male Sprague–Dawley rats (8 weeks old, 180 – 230 g) were used to establish a pressure-overload model as described previously. All animals were separated into four groups (10 rats per group): (i) vehicle-treated sham group; (ii) MG132-treated sham group; (iii) vehicle-treated abdominal aortic banding (AAB) group; and (iv) MG132-treated AAB group. Under intraperitoneal pentobarbital (50 mg/kg) anesthesia, AAB was created using a 5-0 suture tied twice around the abdominal aorta in which. a 21-gauge needle was inserted. The needle was then retracted yielding a 70 – 80% constriction with an outer aortic diameter of 0.8 mm. In the sham surgery rats, the same surgery was performed as described above except the aorta was constricted. At Day 3 after the surgery, MG132-treated rats were intraperitoneally injected with 0.1 mg/kg/day of MG132 for 8 weeks. All control animals were injected with a corresponding volume of vehicle only (0.1% DMSO) [4]. Sixteen-week-old male CD1 mice were used for all our experiments. Thirty minutes before the immobilization procedure, 0.1 mg/kg of buprenorphine was administrated IP. The mice were then anesthetized using isoflurane. The right hindlimb was immobilized as previously described. Briefly, the hindlimb was immobilized 7 days by stapling the foot exploiting normal dorso-tibial flexion using an Autosuture Royal 35W skin stapler. One tine was inserted close to the toe at the plantar portion of the foot while the other was inserted in the distal portion of the gastrocnemius. The other hindlimb was used as a control. During the immobilization period, the mice were injected subcutaneously with MG132 (7.5 mg/kg/dose) or vehicle (DMSO) twice daily. DMSO containing or not MG132 was diluted in sterile pure corn oil (1:100, injected volume 150 μL). After 7 days, the tibialis anterior (TA) muscles of immobilized and non-i
体外活性方法:人宫颈癌细胞 HeLa 用 MG-132 (0.5-30 μM) 处理 24 h,使用 MTT 方法检测细胞生长抑制情况。 结果:MG-132 剂量依赖性地抑制 HeLa 细胞生长,IC50 约为 5 μM。[1] 方法:人间皮瘤细胞 NCI-H2452 用 MG-132 (0.25-2 μM) 处理 36 h,使用 Western Blot 方法检测靶点蛋白表达水平。 结果:MG-132 处理诱导 NCI-H2052 细胞中 caspases 3、caspases 7、Bid 和 PARP 的切割,诱导 caspase 依赖性凋亡。[2] 方法:人类黑色素瘤细胞 MeWo 用 MG-132 (0.01-1 μM) 处理 24 h,使用 Flow Cytometry 方法分析细胞周期情况。 结果:MG-132 诱导 MeWo 细胞的细胞周期阻滞在 G2 期。[3]
体内活性方法:为检测体内抗肿瘤活性,将 MG-132 (1 mg/kg) 静脉注射给携带人宫颈癌肿瘤 HeLa、CaSki 或 C33A 的 C.B‐17/lcr‐scid/scidJcl 小鼠,每周两次,持续四周。 结果:MG-132 治疗显著抑制人宫颈癌肿瘤的生长,表明在体内具有抗肿瘤活性。[4] 方法:为研究 MG-132 长期治疗对心肌肥大的影响及其相关分子机制,将 MG-132 (0.1 mg/kg) 腹腔注射给具有腹主动脉束带(AAB)的大鼠,每天一次,持续八周。 结果:MG-132 治疗显著减弱了 AAB 大鼠的左心室肌细胞面积、左心室重量/体重和肺重量/体重比,降低了左心室舒张直径和壁厚,并增加了缩短分数。MG-132 治疗可显著逆转 AAB 大鼠 ERK1/2 和 JNK1 磷酸化水平的升高。[5]
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度H2O : Insoluble
Ethanol : 47.5 mg/mL (100 mM)
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 9 mg/mL (18.92 mM), Please add co-solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately.
DMSO : 45 mg/mL (94.61 mM)
关键字proteolytic | Proteasome | peptide | MG-132 | MG132 | MG 132 | Inhibitor | inhibit | complex | calpain | Autophagy | Apoptosis | aldehyde | 26S
相关产品Guanidine hydrochloride | Naringin | Valproic Acid | L-Glutamic acid | Gefitinib | Hydroxychloroquine | Dextran sulfate sodium salt (MW 4500-5500) | Stavudine | Tributyrin | L-Ascorbic acid | Paeonol | Sodium 4-phenylbutyrate
相关库抑制剂库 | 抗癌活性化合物库 | 经典已知活性库 | 已知活性化合物库 | 细胞凋亡化合物库 | 抗衰老化合物库 | 蛋白酶抑制剂库 | 抗COVID-19化合物库 | NO PAINS 化合物库 | 泛素化化合物库 | 血液病分子库 | 共价抑制剂库
Z-LLL-al|||Z-Leu-Leu-Leu-CHO|TargetMol

公司简介

上海陶术生物科技有限公司为美国Target Molecule Corp. ( Target Mol ) 在上海建立的全资子公司。我们与美国波士顿、德国慕尼黑的同事一起,为北美、欧洲和亚洲从事药物研发和生物学研究的科学家提供优质的产品和专业的服务。公司下设筛选事业部,化学事业部,生物事业部和新材料部。 从虚拟筛选到实体化合物分子供应;从商业化产品销售到个性化定制合成;从对明确靶点的分子筛选到对明确分子的多靶点筛选,从高通量筛选到化学结构优化,我们都可以满足您的科研用品及技术服务的需求。 经过在中国市场五年的精心耕耘,我们已成为筛选化合物领域优秀的供应商,为超过五百家学校和各类企业提供了品质卓越的小分子化合物和药物筛

成立日期 (12年)
注册资本 566.2651万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,试剂,定制,服务
主营行业 化学试剂,生物活性小分子

化合物 MG-132相关厂家报价 更多

  • MG-132
  • MG-132
  • 杭州信海医药科技有限公司 VIP
  • 2024-12-18
  • ¥800
  • MG-132
  • MG-132
  • 上海芮晖化工科技有限公司 VIP
  • 2024-11-08
  • 询价
内容声明
拨打电话 立即询价